Abstract
This report covers a case of severe psoriasis that appeared to respond well to treatment with subcutaneous etanercept, with good recovery of the arthropathic component. However, there were distinct areas at the patient’s hands and wrists that failed to respond to such treatment. A standard series of patch tests yielded strong positive responses to the vaseline ointment and mercaptobenzothiazole mix, substances that the patient had constantly applied, twice daily, before and during the anti-tumour necrosis factor alpha therapy course, as an emollient, rubber-gloved topical treatment. This case is reported to provide further evidence of the efficacy of etanercept treatment, and to confirm that the immunopathological pathway leading to psoriasis and allergic contact dermatitis (ACD) sometimes goes into ‘overdrive’ in ACD, giving a mixed pattern, involving each of the branches of the immune system.
Similar content being viewed by others
References
Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349: 2014–22
Jin Y, Yang S, Zhang F, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital based case–control study in China. J Eur Acad Dermatol Venereol 2009; 23: 132–7
Masjedi K, Ahlborg N, Gruvberger B, et al. Methylisothiazolinones elicit increased production of both T helper (Th)1- and Th2-like cytokines by peripheral blood mononuclear cells from contact allergic individuals. Br J Dermatol 2003; 149: 1172–82
Minang JT, Areström I, Troye-Blomberg M, et al. Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-type cytokine response in vitro in subjects with contact allergy to the respectivemetals. Clin Exp Immunol 2006; 146: 417–26
Acknowledgments
The authors would like to thank Mrs Domenica Scacciavillani, chief nurse at the Dermatology Unit, who provided practical management of patch testing and all other nursing issues, and Marie Cheeseman of inScience Communications who provided assistance with English-language editing. This assistance was funded by Pfizer. The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Agnusdei, C.P., Mastronardi, C. A Case of Severe Psoriasis with an Apparent Incomplete Response to Anti-Tumour Necrosis Factor Alpha Treatment. AM J Clin Dermatol 11 (Suppl 1), 41–43 (2010). https://doi.org/10.2165/1153422-S0-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/1153422-S0-000000000-00000